{"DataElement":{"publicId":"6686595","version":"1","preferredName":"Prior Systemic Therapy High dose Interleukin-2 Administered End Date","preferredDefinition":"The last date of the prior administration of systemic therapy HD IL-2.","longName":"6686593v1.0:2188674v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6686593","version":"1","preferredName":"Prior Systemic Therapy High dose Interleukin-2 Administered","preferredDefinition":"Earlier in time or order._Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body._No value exists._Interleukin-2 (153 aa, ~18 kDa) is encoded by the human IL2 gene. This protein is involved in T-cell proliferation, leukocyte stimulation and immune responses._The act of having given something (e.g., a medication or test).","longName":"2206845v1.0:6686591v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2206845","version":"1","preferredName":"Prior Systemic Therapy","preferredDefinition":"Earlier in time or order.:(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","longName":"C25629:C15698","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Systemic Therapy","conceptCode":"C15698","definition":"Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0AE3-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6686591","version":"1","preferredName":"High dose Interleukin-2 Administered","preferredDefinition":"No value exists.:Interleukin-2 (153 aa, ~18 kDa) is encoded by the human IL2 gene. This protein is involved in T-cell proliferation, leukocyte stimulation and immune responses.:The act of having given something (e.g., a medication or test).","longName":"CL213860:C20507:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High dose","conceptCode":"CL213860","definition":"No value exists.","evsSource":"NCI_META_CUI","primaryIndicator":"No","displayOrder":"2"},{"longName":"Interleukin-2","conceptCode":"C20507","definition":"Interleukin-2 (153 aa, ~18 kDa) is encoded by the human IL2 gene. This protein is involved in T-cell proliferation, leukocyte stimulation and immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85B1B5F0-569E-573D-E053-F662850A49FD","latestVersionIndicator":"Yes","beginDate":"2019-04-04","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-04","modifiedBy":"ONEDATA","dateModified":"2019-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85B1B5F0-56AF-573D-E053-F662850A49FD","latestVersionIndicator":"Yes","beginDate":"2019-04-04","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-04","modifiedBy":"MORENOC","dateModified":"2020-01-07","changeDescription":"1/7/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2188674","version":"1","preferredName":"End Date","preferredDefinition":"The date on which an observation or an event ended.","longName":"END_DT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"format":"mm/dd/yy","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184285","version":"1","preferredName":"Date","preferredDefinition":"A particular day specified as the time something has, or will, happen.","longName":"Date","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1B1A-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E53ADB93-5DF7-315A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-29","modifiedBy":"KNABLEJ","dateModified":"2017-08-23","changeDescription":"8/23/17 jk transferred context, cap first letter in def, and added CSI, registration status per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"last day of HD IL-2","type":"Preferred Question Text","description":"last day of HD IL-2","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85A70981-80F1-3A0C-E053-F662850A88B0","latestVersionIndicator":"Yes","beginDate":"2019-04-04","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-04","modifiedBy":"MORENOC","dateModified":"2020-01-07","changeDescription":"1/7/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}